secwatch.observer — SEC 8-K summary
======================================

Issuer:     GreenLight Biosciences Holdings, PBC (—)
CIK:        0001822691
Form:       8-K
Filed at:   2023-05-31T23:59:59+00:00
Accession:  0000950170-23-025357
Event type: other_material
Sentiment:  negative
Materiality: 0.80
Item codes: 2.05
LLM model:  deepseek-v4-flash:cloud@v2

GreenLight Biosciences cuts 51% of workforce, expects $6-8M restructuring charge
--------------------------------------------------------------------------------

- Board authorized restructuring plan to extend cash runway; workforce reduced by approximately 51%.
- Pre-tax restructuring charge of $6 to $8 million expected in Q2 2023, primarily cash expenditures.
- Actions substantially complete by Q3 2023, subject to local law requirements.
- Reduction targets employees supporting programs without anticipated short-term value creation.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1822691/000095017023025357/0000950170-23-025357-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1822691/000095017023025357/grna-20230530.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-025357

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer